| Mr Douglas R Cameron, MS | |
|
2155 Electric Rd, Suite C, Roanoke, VA 24018-2302 | |
| (540) 774-4441 | |
| (540) 774-3393 |
| Full Name | Mr Douglas R Cameron |
|---|---|
| Gender | Male |
| Speciality | Qualified Audiologist |
| Experience | 34 Years |
| Location | 2155 Electric Rd, Roanoke, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548258478 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 2201000533 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hearing Health Associates Pc | 5395895700 | 2 |
News Archive
More than 53 million Americans age 50 and older, primarily women, have osteoporosis or are at high risk for the condition due to low bone density. A recent study of oral bisphosphonates, the most commonly prescribed osteoporosis treatment, found that approximately a third of women prescribed these drugs continue to be at elevated risk for bone fracture, an outcome that may have several origins.
"The Department of Veterans Affairs yesterday apologized repeatedly for a prostate-cancer program that gave incorrect radiation doses to veterans for six years at its main Philadelphia hospital," The Philadelphia Inquirer reports.
A surprising discovery about a rare form of childhood brain cancer suggests a new treatment approach for that cancer and, potentially, many others.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Anastrozole tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 8 days ago
| Provider Name | Hearing Health Associates Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1427147198 PECOS PAC ID: 5395895700 Enrollment ID: O20090605000195 |
News Archive
More than 53 million Americans age 50 and older, primarily women, have osteoporosis or are at high risk for the condition due to low bone density. A recent study of oral bisphosphonates, the most commonly prescribed osteoporosis treatment, found that approximately a third of women prescribed these drugs continue to be at elevated risk for bone fracture, an outcome that may have several origins.
"The Department of Veterans Affairs yesterday apologized repeatedly for a prostate-cancer program that gave incorrect radiation doses to veterans for six years at its main Philadelphia hospital," The Philadelphia Inquirer reports.
A surprising discovery about a rare form of childhood brain cancer suggests a new treatment approach for that cancer and, potentially, many others.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Anastrozole tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Douglas R Cameron, MS 2155 Electric Rd, Suite C, Roanoke, VA 24018-2302 Ph: (540) 774-4441 | Mr Douglas R Cameron, MS 2155 Electric Rd, Suite C, Roanoke, VA 24018-2302 Ph: (540) 774-4441 |
News Archive
More than 53 million Americans age 50 and older, primarily women, have osteoporosis or are at high risk for the condition due to low bone density. A recent study of oral bisphosphonates, the most commonly prescribed osteoporosis treatment, found that approximately a third of women prescribed these drugs continue to be at elevated risk for bone fracture, an outcome that may have several origins.
"The Department of Veterans Affairs yesterday apologized repeatedly for a prostate-cancer program that gave incorrect radiation doses to veterans for six years at its main Philadelphia hospital," The Philadelphia Inquirer reports.
A surprising discovery about a rare form of childhood brain cancer suggests a new treatment approach for that cancer and, potentially, many others.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Anastrozole tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 8 days ago
Kevin E Mccurdy, CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 325 Elm Ave Se, Roanoke, VA 24013 Phone: 540-343-5567 | |
Kristina S Miller, AU.D., CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 3 Riverside Cir, Roanoke, VA 24016 Phone: 540-224-5170 | |
Tammy Brooks Garber, M.S. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2155 Electric Rd, Suite C, Roanoke, VA 24018 Phone: 540-774-4441 Fax: 540-774-3393 | |
Mrs. Heather B Dickey, MSCCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2030 Colonial Ave Sw, Roanoke, VA 24015 Phone: 540-343-0165 Fax: 540-343-4664 | |
Roanoke Valley Speech And Hearing Center, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2030 Colonial Ave Sw, Roanoke, VA 24015 Phone: 540-343-0165 Fax: 540-345-4664 | |
Michelle Ann Ickes, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2030 Colonial Ave Sw, Roanoke, VA 24015 Phone: 540-343-0165 | |
Hearing Health Associates, Pc Audiologist Medicare: Medicare Enrolled Practice Location: 2155 Electric Rd, Suite C, Roanoke, VA 24018 Phone: 540-774-4441 Fax: 540-774-3393 |